Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celera CORP | 18,725,217 | reported | 12 May 2011 | tx 22+4,699,025 |
| ARQULE INC | 11,608,760 | reported | 12 Nov 2008 | tx 24+3,081,900 |
| AVIGEN INC \DE | 7,878,915 | reported | 07 Nov 2008 | tx 6+127,500 |
| ADOLOR CORP | 6,194,551 | reported | 30 Oct 2008 | tx 6+87,900 |
| DYNAVAX TECHNOLOGIES CORP | 5,899,457 | reported | 30 Jul 2009 | tx 6−37,600 |
| NPS PHARMACEUTICALS INC | 4,751,015 | reported | 14 Mar 2008 | tx 6+108,300 |
| NEUROCRINE BIOSCIENCES INC | 3,527,700 | reported | 12 Oct 2011 | tx 52+1,394,247 |
| GYRE THERAPEUTICS, INC. | 2,977,919 | reported | 16 Nov 2012 | tx 2+595,000 |
| ChemoCentryx, Inc. | 2,744,577 | reported | 02 Nov 2015 | tx 12+1,425,420−50,000 |
| LIGAND PHARMACEUTICALS INC | 279,842 | reported | 20 Feb 2014 | tx 43+2,567,394−422,900 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Jul 2017 | SALE | ORTHOLOGIC CORP | 105,713 | 0.06 USD | |
| 14 Jul 2017 | SALE | ORTHOLOGIC CORP | 242,236 | 0.06 USD | |
| 14 Jul 2017 | SALE | ORTHOLOGIC CORP | 3,993,637 | 0.06 USD | |
| 02 Nov 2015 | SALE | ChemoCentryx, Inc. | 50,000 | 6.97 USD | |
| 19 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 5,395 | 73.03 USD | |
| 19 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 9,464 | 73.03 USD | |
| 18 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 14,003 | 74.66 USD | |
| 18 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 153,751 | 74.66 USD | |
| 18 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 16,331 | 74.66 USD | |
| 18 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 16,915 | 74.66 USD | |
| 19 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 57,370 | 73.03 USD | |
| 20 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 18,615 | 73.05 USD | |
| 19 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 2,771 | 73.03 USD | |
| 20 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 10,557 | 73.05 USD | |
| 20 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 112,369 | 73.05 USD | |
| 20 Feb 2014 | SALE | LIGAND PHARMACEUTICALS INC | 5,359 | 73.05 USD | |
| 04 Nov 2013 | PURCHASE | ChemoCentryx, Inc. | 5,500 | 4.90 USD | |
| 05 Nov 2013 | PURCHASE | ChemoCentryx, Inc. | 35,526 | 4.97 USD | |
| 05 Nov 2013 | PURCHASE | ChemoCentryx, Inc. | 74,684 | 4.97 USD | |
| 06 Nov 2013 | PURCHASE | ChemoCentryx, Inc. | 11,985 | 4.69 USD | |
| 06 Nov 2013 | PURCHASE | ChemoCentryx, Inc. | 8,371 | 4.69 USD | |
| 08 Oct 2013 | PURCHASE | ChemoCentryx, Inc. | 30,406 | 5.31 USD | |
| 08 Oct 2013 | PURCHASE | ChemoCentryx, Inc. | 401,675 | 5.35 USD | |
| 09 Oct 2013 | PURCHASE | ChemoCentryx, Inc. | 53,271 | 5.26 USD | |
| 09 Oct 2013 | PURCHASE | ChemoCentryx, Inc. | 29,564 | 5.26 USD |
1 purchase reported after at least 12 months of silence — most recent on 07 Apr 2011.